PharmaShots | Incisive News in 3 Shots

Subscribe Now

BioNTech

BioNTech and OncoC4 Initiate Pivotal P-III Trial of Gotistobart (BNT316/ONC-392) in Patients with Metastatic Non Small Cell Lung Cancer

BioNTech and OncoC4 Initiate Pivotal P-III Trial of Gotistobart (BNT316/ONC-392) in Patients with Metastatic Non Small Cell Lung C...

June 30, 2023

BioNTech Signed an Exclusive License and Collaboration Agreements with DualityBio for Two ADC Therapies to Treat Solid Tumors

BioNTech Signed an Exclusive License and Collaboration Agreements with DualityBio for Two ADC Therapies to Treat Solid Tumors

April 3, 2023

BioNTech Signs an Exclusive Worldwide License and Collaboration Agreement with OncoC4 to Co-Develop and Commercialize ONC-392

BioNTech Signs an Exclusive Worldwide License and Collaboration Agreement with OncoC4 to Co-Develop and Commercialize ONC-392

March 21, 2023

BioNTech to Acquire InstaDeep for ~$683M

BioNTech to Acquire InstaDeep for ~$683M

January 12, 2023

BioNTech Entered into a Multi-Target Research Collaboration with Ryvu Therapeutics to Develop and Commercialize Immuno-Modulatory Small Molecule Candidates

BioNTech Entered into a Multi-Target Research Collaboration with Ryvu Therapeutics to Develop and Commercialize Immuno-Modulatory...

December 1, 2022

BioNTech Entered into an Exclusive Research Collaboration with Matinas BioPharma to Evaluate Novel Delivery Technology for mRNA-Based Vaccines

BioNTech Entered into an Exclusive Research Collaboration with Matinas BioPharma to Evaluate Novel Delivery Technology for mRNA-Ba...

April 12, 2022

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us